IVD Market Worth USD 15.71 Billion Has Evolved Significantly in BRIC Countries

Author : BloggerDJ
Publish Date : 2021-05-04


IVD Market Worth USD 15.71 Billion Has Evolved Significantly in BRIC Countries

This report aims to provide detailed insights into the IVD market in BRIC countries. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Key Factors Driving Market Growth:

The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.

Expected Revenue Growth:

The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%.

This research study involved the extensive use of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198

IVD Applications:

Based on application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and others. The infectious diseases segment accounted for the largest share of the market in 2016, owing to the rising incidence of tuberculosis (TB), hepatitis, and hospital-acquired infections.

IVD Technologies:

BRIC IVD Market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The Molecular Diagnostics segment is estimated to register the highest CAGR during the forecast period of 2017 to 2022. The rising prevalence of infectious diseases, cancer, and various genetic disorders; growing demand for blood screening; and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing is expected to drive the growth of the market during the forecast period.

Regional Growth Analysis:

Geographically, China dominated the BRIC IVD Market and other emerging countries in 2016. The large share of this country can be attributed to rising healthcare expenditure, increasing acceptance of personalized medicine, and increasing awareness towards technologically advanced products in this country. China is also expected to register the highest CAGR, due to the growth in research activities and increasing investments by leading players and government agencies in the country.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=198

BRIC IVD Market is segmented into hospital-based laboratories, clinical/reference laboratories, academic institutes, point-of-care testing, patient self-testing, and other end users. The hospital-based laboratories segment accounted for the largest share of the market in 2016. The large share of this segment can be attributed to the large number of diagnostic tests carried out in hospitals.

Key Players in IVD Market:

The key players in this BRIC IVD Market are Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), QIAGEN N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).

Target Audience

  • IVD product manufacturers
  • Group purchase organizations (GPOs)
  • Original equipment manufacturers (OEM)
  • Pathologists and pathology laboratories
  • Distributors of IVD products
  • Hospitals and clinics
  • Healthcare institutions
  • Research institutes
  • Market research and consulting Firms

Scope of the Report

This research report categorizes the BRIC IVD Market and other emerging countries into the following segments:

BRIC IVD Market, by Product & Service

  • Reagents & Kits
  • Instruments
  • Services
  • Data Management Software

BRIC IVD Market, by Technology

  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemical Tests
  • Immunochemistry/Immunoassay
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Hematology
  • Coagulation & Hemostasis
  • Clinical Microbiology
  • Molecular Diagnostics (MDx)
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Microarrays
    • Hybridization
    • DNA Sequencing & Next-generation Sequencing
    • Other MDx technologies
  • Other Technologies

BRIC IVD Market, by Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV/Aids
  • Other Applications

BRIC IVD Market, by End User

  • Hospital-based Laboratories
  • Clinical/Reference Laboratories
  • Academic Institutes
  • Point-of-care Testing
  • Patient Self-Testing
  • Other End Users

BRIC IVD Market and Other Emerging Countries, by Country

  • Russia
  • Turkey
  • China
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Saudi Arabia

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Market Size Analysis

  • Detailed market size analysis of additional emerging countries (Up to 5)

Market Share Analysis

  • Detailed market share analysis of market players (Up to 5)

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Industry Insights (Page No. - 41)
    5.1 Introduction
    5.2 Industry Trends
           5.2.1 High Focus of IVD Players on China
           5.2.2 Microfluidics-Based POC and LOC Diagnostic Devices for Laboratory Testing
           5.2.3 Rise in Number of Reagent Rental Agreements
    5.3 Regulatory Overview
           5.3.1 China
           5.3.2 India
           5.3.3 Malaysia
           5.3.4 Thailand
           5.3.5 Indonesia
           5.3.6 Russia
           5.3.7 Saudi Arabia
           5.3.8 Mexico
           5.3.9 South Korea

6 BRIC IVD Market Overview (Page No. - 49)
    6.1 Introduction
    6.2 Market Dynamics
           6.2.1 Market Drivers
                    6.2.1.1 Rising Incidence of Chronic Lifestyle Diseases
                    6.2.1.2 Rapid Growth in the Geriatric Population
                    6.2.1.3 Increasing Adoption of Point-Of-Care Testing
                    6.2.1.4 Growing Awareness of Personalized Medicine
                    6.2.1.5 Growth in the Number of Private Diagnostic Centers
           6.2.2 Market Restraints
                    6.2.2.1 Inadequate Reimbursement
                    6.2.2.2 Economic Slowdown in Latin America
           6.2.3 Market Opportunities
                    6.2.3.1 Improving Healthcare Systems in Emerging Markets
                    6.2.3.2 Growing Significance of Companion Diagnostics
           6.2.4 Market Challenges
                    6.2.4.1 Stringent Regulatory Framework in Latin America
                    6.2.4.2 Operational Barriers to the Use of Diagnostic Tests

7 BRIC IVD Market, By Product & Service (Page No. - 60)
    7.1 Introduction
    7.2 Reagents & Kits
    7



Category :business

再見街貓BOB▷ 完整版本 (2020-HD) A Gift From BOB 完整版觀看電

再見街貓BOB▷ 完整版本 (2020-HD) A Gift From BOB 完整版觀看電

- https://kerricooke9.tumblr.com/post/637417275444592640/a-gift-from-bob


Go with Actual CompTIA 220-1002 Questions for a Big Hit in the Final Exam

Go with Actual CompTIA 220-1002 Questions for a Big Hit in the Final Exam

- The networking world is witnessing ever-increasing advancement in its why is Crack the HPE2-CP08 Exam Through HP HPE2-CP08 Dumps {2021}


Its Always A Good Time To Learn More About Personal Finances

Its Always A Good Time To Learn More About Personal Finances

- In todays difficult economic times, everyone is looking for ways to improve their personal financial situation. The key to successfully


What Small Business Tips Can You Learn From Animal Crossing?

What Small Business Tips Can You Learn From Animal Crossing?

- While its easy to dismiss the title as a kids game, there are a surprising number of entrepreneurial takeaways – from business growth to